VivoSim Labs, Inc.
VIVS
$1.47
$0.053.52%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 112.50% | -20.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 112.50% | -20.00% | |||
| Cost of Revenue | -51.80% | 80.91% | |||
| Gross Profit | 54.04% | -84.08% | |||
| SG&A Expenses | 37.19% | 3.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.22% | 32.37% | |||
| Operating Income | 9.05% | -32.98% | |||
| Income Before Tax | 298.78% | -35.23% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 298.78% | -35.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 298.78% | -35.23% | |||
| EBIT | 9.05% | -32.98% | |||
| EBITDA | 9.06% | -33.90% | |||
| EPS Basic | 269.79% | -34.77% | |||
| Normalized Basic EPS | 22.00% | -34.77% | |||
| EPS Diluted | 269.79% | -34.77% | |||
| Normalized Diluted EPS | 22.00% | -34.77% | |||
| Average Basic Shares Outstanding | -91.69% | 0.34% | |||
| Average Diluted Shares Outstanding | -91.69% | 0.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||